Spiraeoside inhibits mast cells activation and IgE-mediated allergic responses by suppressing phospholipase C-γ-mediated signaling

Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
Jung Kuk KimPann-Ghill Suh

Abstract

Mast cells are responsible for IgE-mediated allergic responses through the secretion of various inflammatory cytokines and mediators. Therefore, the pharmacological regulation of mast cell activation is an important goal in the development of novel anti-allergic drugs. In this study, we found that spiraeoside (SP) inhibits mast cell activation and allergic responses in vivo. SP dose-dependently inhibited the degranulation induced by IgE-antigen (Ag) stimulation in RBL-2H3 mast cells without cytotoxic effects. At the molecular level, SP reduced the Ag-induced phosphorylation and subsequent activation of phospholipase C-γ2 (PLC-γ2). Moreover, SP inhibited the phosphorylation of spleen tyrosine kinase (Syk), linker for activation of T cells (LAT), and downstream MAPKs, such as ERK1/2, p38, and JNK, eventually attenuating expression of TNF-α and IL-4. Finally, we found that SP significantly inhibited IgE-mediated passive cutaneous anaphylaxis (PCA) in mice. Taken together, our results strongly suggest that SP suppresses IgE-mediated mast cell activation and allergic responses by inhibiting Lyn-induced PLC-γ2/MAPK signaling in mast cells.

References

Dec 1, 1995·The American Journal of Clinical Nutrition·P C HollmanM B Katan
Oct 18, 2000·Free Radical Biology & Medicine·C F Skibola, M T Smith
Jun 8, 2001·Annual Review of Biochemistry·S G Rhee
Mar 4, 2003·The Journal of Nutrition·Aloys L A SesinkPeter C H Hollman
Apr 6, 2004·American Journal of Physiology. Lung Cellular and Molecular Physiology·Chiang-Wen LeeChuen-Mao Yang
Jun 9, 2004·The British Journal of Nutrition·Rainer CermakSiegfried Wolffram
Apr 5, 2005·The Journal of Allergy and Clinical Immunology·Eli O MeltzerElliott B Grossbard
Aug 17, 2005·The Journal of Pharmacy and Pharmacology·Alyson M BrowningThomas Walle
Dec 2, 2005·The European Respiratory Journal·S N GeorasV Casolaro
Feb 14, 2006·Nature Reviews. Immunology·Alasdair M Gilfillan, Christine Tkaczyk
Jun 6, 2006·The Journal of Allergy and Clinical Immunology·Juan Rivera, Alasdair M Gilfillan
Jul 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Koki KabuToshio Hirano
Dec 29, 2006·Annals of the New York Academy of Sciences·Theoharis C Theoharides, Dimitrios Kalogeromitros
Mar 6, 2007·Fitoterapia·Zoran MaksimovićJelena Kukić
Nov 23, 2007·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J M BrownD D Metcalfe
Feb 16, 2008·Nature Reviews. Immunology·Stephen T Holgate, Riccardo Polosa
Apr 9, 2008·The Journal of Allergy and Clinical Immunology·Jun Ho LeeWahn Soo Choi
Apr 18, 2008·European Journal of Pharmacology·Agnes W BootsAalt Bast
Oct 2, 2008·Current Opinion in Clinical Nutrition and Metabolic Care·Stephan C Bischoff
Oct 22, 2008·Nature Immunology·Janet Kalesnikoff, Stephen J Galli
Apr 28, 2009·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Eun Hee HanHye Gwang Jeong
May 9, 2009·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Eun Hee HanHye Gwang Jeong
Dec 25, 2009·The Journal of Nutrition·Ock K ChunSung I Koo
Apr 13, 2010·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Eun-Ju LeeMi-Kyung Sung

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.